DE LAS COMPETICIONES

CHAPTER 13 Hypersensitivity 221

13. Which of the following explains the difference between type II and type III hypersensitivity reactions? a. Type II involves cellular antigens.

b. Type III involves IgE.

c. IgG is involved only in type III reactions. d. Type II reactions involve no antibody.

14. A 37-year-old woman received two units of packed red blood cells following a surgical procedure. She had been transfused once before. Five days after surgery, she experienced a slight fever and some hemoglobin in her urine, indicating a delayed transfusion reaction. A DAT test on a blood sample was positive. Which of the fol- lowing statements best describes this reaction? a. The patient had IgM antibody to the red cells

transfused.

b. The patient’s reaction was due to an amnestic response.

c. Only IgE was coating the transfused red blood cells. d. The antibody present reacted best at room

222 SECTION 3 Immune Disorders

References

1. Kindt, TJ, Goldsby, RA, and Osborne, BA. Kuby Immunology, ed. 6. WH Freeman and Company, New York, 2007, pp. 371–400. 2. Host, A, Andraes, S, Charkin, S, Diaz-Vaquez, C, et al. Allergy testing in children: Why, who, when, and how. Allergy 58: 559–569, 2003.

3. Mothes, N, Valenta, R, and Spitzauer, S. Allergy testing: The role of recombinant allergens. Clin Chem Lab Med 44: 125–132, 2006.

4. Gould, HJ, Sutton, BJ, Beavil, AJ, Beavil, RL, et al. The biol- ogy of IgE and the basis of allergic disease. Ann Rev Immunol 21:579–628, 2003.

5. Kay, AB. Allergy and allergic diseases, Part I. N Engl J Med 344:30–37, 2001.

6. Homberger, HA. Allergic diseases. In McPherson, RA, and Pincus, MR (eds): Henry’s Clinical Diagnosis and Management by Laboratory Methods, ed. 21. Saunders Elsevier, Philadelphia, 2007, pp. 961–971.

7. Mak, TW, and Saunders, ME. The Immune Response: Basic and Clinical Principles. Elsevier Academic Press, Burlington, MA, 2006, pp. 923–962.

8. Jutel, M, Blaser, K, and Akdis, CA. Histamine in allergic inflammation and immune modulation. Int Arch Allergy Immunol 137:82–92, 2005.

9. Abramson, J, and Pecht, I. Regulation of the mast cell response to the type 1 Fc epsilon receptor. Immunol Rev 217:231–254, 2007.

10. Li, JT. Allergy testing. Am Fam Physician 66:621–624, 2002. 11. Taylor, JS, and Erkek, E. Latex allergy: Diagnosis and man-

agement. Dermatol Ther 17:289–301, 2004.

12. Zak, HN, Kaste, LM, Schwarzenberger, K, et al. Health-care workers and latex allergy. Arch Environ Health 55:336–347, 2000.

13. Berger, WE. Monoclonal anti-IgE antibody: A novel therapy for allergic airways disease. Ann Allergy, Asthma, Immunol 88:152–160, 2002.

14. Kay, AB. Allergy and allergic diseases, Part II. N Engl J Med 344:109–113, 2001.

15. Platts-Mills, T, Leung, DYM, and Schatz, M. The role of allergens in asthma. Am Fam Physician 76:675–680, 2007. 16. Plaut, M, and Valentine, MD. Allergic rhinitis. N Engl J Med

353:1934–44, 2005.

17. Hughes, ATD. Anti-IgE antibody may help treat some asthma patients. JAMA 284:2859–2890, 2000.

18. Milgrom, H, Fick, RB Jr., Su, JQ, et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med 341(26):1966–1973, 1999.

19. Hamilton, RG. Immunological methods in the diagnostic allergy clinical and research laboratory. In Detrick, B, Hamilton, RG, and Folds, JD (eds): Manual of Molecular and Clinical Laboratory Immunology, ed. 7. ASM Press, Washington, DC, 2006, pp. 955–963.

20. Milgrom, H. Is there a role for treatment of asthma with oma- lizumab? Arch Dis Child 88:71–74, 2003.

21. Damin, DA, and Peebles, Jr., RS. In vivo diagnostic allergy testing. In Detrick, B, Hamilton, RG, and Folds, JD (eds): Manual of Molecular and Clinical Laboratory Immunology, ed. 7. ASM Press, Washington, DC, 2006, pp. 947–954. 22. Cobbaert, CM, and Jonker, GJ. Allergy testing on the

Immulite 2000 random-access immunoanalyzer—a clinical evaluation study. Clin Chem Lab Med 43:772–781, 2005.

23. Smits, WM, Letz, KL, Evans, TS, and Giese, JK. Evaluating the response of patients undergoing both allergy skin testing and in vitro allergy testing with the ImmunoCAP technology system. J Am Acad Nurse Pract 15:415–423, 2003.

24. Fleischer, DM, and Wood, RA. Tests for immunological reac- tions to foods. In Detrick, B, Hamilton, RG, and Folds, JD (eds): Manual of Molecular and Clinical Laboratory Immunology, ed. 7. ASM Press, Washington, DC, 2006, pp. 975–983. 25. Renault, NK, Mirotti, L, and Alcocer, MJC. Biotechnologies

in new high-throughput food allergy tests: Why we need them. Biotechnol Lett 29:333–339, 2007.

26. Harwanegg, C, Laffer, S, Hiller, R, Mueller, MW, et al. Microarrayed recombinant allergens for diagnosis of allergy. Clin Exp Allergy 33:7–13, 2003.

27. Garratty, G, Dzik, W, Issitt, PD, et al. Terminology for blood group antigens and genes—historical origins and guidelines in the new millennium. Transfusion 40:477–489, 2000. 28. Storry, JR, and Olsson, ML. Genetic basis of blood group

diversity. Brit J Haematol 126:759–771, 2004.

29. Dzieckowski, JS, and Anderson, KC. Transfusion biology and therapy. In Kasper, DL, Braunwald, E, Fauci, AE, Hauser, SL, et al. (eds): Harrison’s Principles of Internal Medicine, ed. 16. McGraw-Hill, New York, 2005, pp. 662–667.

30. Davenport, RD, and Mintz, PD. Transfusion medicine. In McPherson, RA, and Pincus, MR (eds): Henry’s Clinical Diagnosis and Management by Laboratory Methods, ed. 21. Saunders Elsevier, Philadelphia, 2007, pp. 669–684.

31. Beadling, WV, and Cooling, L. Immunohematology. In McPherson, RA, and Pincus, MR (eds): Henry’s Clinical Diagnosis and Management by Laboratory Methods, ed. 21. Saunders Elsevier, Philadelphia, 2007, pp. 617–668.

32. Reddy, VVB. Extracorporal defects leading to increased erythrocyte destruction—immune causes. In Rodak, BF, Fritzma, GA, and Doig, K (eds): Hematology: Clinical Principles and Applications. Saunders Elsevier, St. Louis, 2007, pp. 325–332.

33. Garratty, G, Glynn, SA, and McEntire, R. ABO and Rh(D) phenotype frequencies of different racial/ethnic groups in the United States. Transfusion 44:703–706, 2004.

34. Mak, TW, and Saunders, ME. The Immune Response: Basic and Clinical Principles. Elsevier Academic Press, Burlington, MA, 2006, pp. 696–749.

35. Murray, NA, and Roberts, IAG. Haemolytic disease of the newborn. Arch Dis Child 92:F83–F88, 2007.

36. Elghetany, MT, and Banki, K. Erythrocytic disorders. In McPherson, RA, and Pincus, MR (eds): Henry’s Clinical Diagnosis and Management by Laboratory Methods, ed. 21. Saunders Elsevier, Philadelphia, 2007, pp. 504–544.

37. Bunn, HF, and Rosse, W. Hemolytic anemias and acute blood loss. In Kasper, DL, Braunwald, E, Fauci, AE, Hauser, SL, et al. (eds): Harrison’s Principles of Internal Medicine, ed. 16. McGraw-Hill, New York, 2005, pp. 607–616.

38. Garvey, B. Rituximab in the treatment of autoimmune haema- tological disorders. Brit J Haematol 141:149–169, 2008. 39. D’Arena, G, Taylor, RP, Cascavilla, N, and Lindorfer, MA.

Monoclonal antibodies: New therapeutic agents for autoim- mune hemolytic anemia? Endocr Metab Immune Disord 8:62–68, 2008.

40. Jacob, SE, and Zapolanski, T. Systemic contact dermatitis. Dermatitis 19:9–15, 2008.

41. Thyssen, JP, Johansen, JD, and Menne, T. Contact allergy epi- demics and their controls. Contact Dermatitis 56:185–195, 2007.

CHAPTER 13 Hypersensitivity 223

42. Karlberg, A, Bergstrom, MA, Borje, A, Luthman, K, et al. Allergic contact dermatitis—formation, structural require- ments, and reactivity of skin sensitizers. Chem Res Toxicol 21:53–69, 2008.

43. Gladman, AC. Toxicodendron dermatitis: Poison ivy, oak, and sumac. Wilderness and Environ Med 17:120–128, 2006. 44. Jacob, SE, and Steele, T. Allergic contact dermatitis: Early

recognition and diagnosis of important allergens. Dermatol Nurs 18:433–446, 2006.

45. Merrill, W. Hypersensitivity pneumonitis: Just think about it. Chest 120:1055–1058, 2001.

46. McCormick, T, and Shearer, W. Delayed-type hypersensitiv- ity skin testing. In Detrick, B, Hamilton, RG, and Folds, JD (eds): Manual of Molecular and Clinical Laboratory Immunology, ed. 7. ASM Press, Washington, DC, 2006, pp. 234–240.